1277-SLC Transporters in Cancer Metabolism

The Solute Carrier (SLC) transporter family, a vast group of over 450 proteins, serves as the primary gateway for moving essential nutrients like glucose, amino acids, and lipids across cell membranes. While these proteins maintain healthy metabolic balance in normal tissues, they are frequently hijacked by cancer cells to fuel rapid growth and resist medical treatment. Key transporters such as GLUT1, LAT1, and xCT drive metabolic reprogramming, helping tumors survive in harsh environments and evade the immune system. Because of their central role in malignancy, these transporters have become high-priority therapeutic targets, with several selective inhibitors currently in preclinical or clinical development. Researchers are exploring personalized medicine strategies that combine SLC inhibition with standard chemotherapy or immunotherapy to overcome drug resistance. Ultimately, targeting the unique metabolic vulnerabilities created by these transporters offers a promising path toward more effective and tailored cancer treatments.References:Zhang X, Feng J, Cai X, et al. The regulatory roles and therapeutic strategies of the solute carrier transporters in cancer metabolism[J]. npj Precision Oncology, 2026.前往小宇宙评论区与主播互动